Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Kelly

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Frontiers in Cellular and Infection Microbiology|February 11, 2020
Assessment of an Antibody-in-Lymphocyte Supernatant Assay for the Etiological Diagnosis of Pneumococcal Pneumonia in ChildrenMichael J Carter, Pallavi Gurung, Claire Jones, et al.
Plos One|June 7, 2014
Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementationSarah Hanieh, Mainga Hamaluba, Dominic F Kelly, et al.
The Pediatric Infectious Disease Journal|January 30, 2026
Causes of Fever in a Cohort of Nepali Children and the Potential Impact of Molecular Testing During a Dengue Fever OutbreakPeter J O'Reilly, Madhav C Gautam, Bhishma Pokhrel, et al.
Vaccine|February 23, 2024
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of ageSanjeev M Bijukchhe, Meeru Gurung, Bhishma Pokhrel, et al.
The Lancet. Infectious Diseases|February 22, 2015
Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trialMainga Hamaluba, Rama Kandasamy, Shyam R Upreti, et al.
The Pediatric Infectious Disease Journal|December 27, 2021
Childhood Invasive Bacterial Disease in Kathmandu, Nepal (2005-2013)Michael J Carter, Meeru Gurung, Bhishma Pokhrel, et al.
The Pediatric Infectious Disease Journal|July 22, 2021
Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese ToddlersMeeru Gurung, Sanjeev M Bijukchhe, Parisa Hariri, et al.
The Lancet. Global Health|September 16, 2022
Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort studyShrijana Shrestha, Meeru Gurung, Puja Amatya, et al.
Nature Communications|October 7, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in BrazilSue Ann Costa Clemens, Pedro M Folegatti, Katherine R W Emary, et al.
The Lancet. Global Health|October 22, 2021
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trialMila Shakya, Merryn Voysey, Katherine Theiss-Nyland, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Cellular and Infection Microbiology|February 11, 2020
Assessment of an Antibody-in-Lymphocyte Supernatant Assay for the Etiological Diagnosis of Pneumococcal Pneumonia in ChildrenMichael J Carter, Pallavi Gurung, Claire Jones, et al.
Plos One|June 7, 2014
Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementationSarah Hanieh, Mainga Hamaluba, Dominic F Kelly, et al.
The Pediatric Infectious Disease Journal|January 30, 2026
Causes of Fever in a Cohort of Nepali Children and the Potential Impact of Molecular Testing During a Dengue Fever OutbreakPeter J O'Reilly, Madhav C Gautam, Bhishma Pokhrel, et al.
Vaccine|February 23, 2024
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of ageSanjeev M Bijukchhe, Meeru Gurung, Bhishma Pokhrel, et al.
The Lancet. Infectious Diseases|February 22, 2015
Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trialMainga Hamaluba, Rama Kandasamy, Shyam R Upreti, et al.
The Pediatric Infectious Disease Journal|December 27, 2021
Childhood Invasive Bacterial Disease in Kathmandu, Nepal (2005-2013)Michael J Carter, Meeru Gurung, Bhishma Pokhrel, et al.
The Pediatric Infectious Disease Journal|July 22, 2021
Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese ToddlersMeeru Gurung, Sanjeev M Bijukchhe, Parisa Hariri, et al.
The Lancet. Global Health|September 16, 2022
Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort studyShrijana Shrestha, Meeru Gurung, Puja Amatya, et al.
Nature Communications|October 7, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in BrazilSue Ann Costa Clemens, Pedro M Folegatti, Katherine R W Emary, et al.
The Lancet. Global Health|October 22, 2021
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trialMila Shakya, Merryn Voysey, Katherine Theiss-Nyland, et al.
Pageof 15